Cladribine tablets receives positive CHMP opinion...

Mavenclad is an oral treatment for relapsing MS and active secondary progressive MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Cladribine tablets receives positive CHMP opinion...

Post by MSUK » Mon Jun 26, 2017 7:18 am

Cladribine tablets receives positive CHMP opinion for treatment of RRMS

Science and technology company, Merck has revealed it has received a positive opinion from the European Medicines Agency (EMA), part of the Committee for Medicinal Products for Human Use (CHMP), for approval of cladribine tablets, also known as Mavenclad. The tablets will be for the treatment of relapsing remitting multiple sclerosis (RRMS) in patients with high disease activity...Read more - http://www.ms-uk.org/cladribine-tablets ... rms-260617
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post